GHHealthcareMid-Cap

Guardant Health, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Guardant Health, Inc. (GH), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are GH insiders buying or selling?

Guardant Health, Inc. insiders reported 8 open-market buys ($65.2M) and 239 sells ($2.9B) across 247 Form 4 filings — a net selling position of $2.8B.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 16, 2026)

Total Form 4 filings
247
SEC EDGAR
Insider filers
23
Insider buys (8)
$65.2M
Insider sells (239)
$2.9B

Insider sentiment

Net selling

Net insider flow of $2.8B in net selling.

Recent GH insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 16, 2026Musa TariqDirectorSale116$163.29$18.9K
Jun 30, 2026Kumud KaliaChief Information OfficerSale600$131.18$78.7K
Jun 30, 2026Amirali TalasazCo-Chief Executive OfficerSale260.0K$151.20$39.3M
Jun 23, 2026Musa TariqDirectorSale2.0K$131.16$255.9K
Jun 23, 2026Myrtle S PotterDirectorSale1.6K$131.16$204.1K
Jun 16, 2026Musa TariqDirectorSale116$130.19$15.1K
Jun 15, 2026Kumud KaliaChief Information OfficerSale3.4K$130.24$445.2K
Jun 12, 2026Kumud KaliaChief Information OfficerSale5.0K$130.41$652.0K
Jun 8, 2026Eltoukhy HelmyCo-Chief Executive OfficerSale100.0K$126.30$12.6M
Jun 8, 2026Michael Brian BellChief Financial OfficerSale2.0K$128.62$257.2K
Jun 5, 2026Steve E. KrognesDirectorSale9.3K$132.51$1.2M
Jun 4, 2026Meghan V. JoyceDirectorSale10.0K$126.98$1.3M
May 29, 2026Medina Manuel HidalgoDirectorSale1.0K$130.06$130.1K
May 28, 2026John G. SaiaChief Legal OfficerSale10.0K$125.08$1.3M
May 26, 2026Chris FreemanChief Commercial OfficerSale24.4K$118.67$2.9M
May 22, 2026John G. SaiaChief Legal OfficerSale20.0K$106.51$2.1M
May 22, 2026Amirali TalasazCo-Chief Executive OfficerSale210.0K$109.89$23.1M
May 22, 2026Ian T ClarkDirectorSale6.9K$106.90$735.0K
May 22, 2026Medina Manuel HidalgoDirectorSale1.3K$107.09$133.9K
May 19, 2026Musa TariqDirectorSale116$95.96$11.1K
May 13, 2026Amirali TalasazCo-Chief Executive OfficerSale50.0K$100.32$5.0M
Apr 16, 2026Musa TariqDirectorSale116$84.83$9.8K
Apr 7, 2026Terilyn J. MonroeChief People OfficerSale3.8K$92.68$355.1K
Mar 19, 2026Musa TariqDirectorSale348$88.09$30.7K
Mar 17, 2026Michael Brian BellChief Financial OfficerSale3.0K$87.04$261.1K

Showing the 25 most recent of 247 Form 4 filings for Guardant Health, Inc..

Most active GH insiders

  • Ian T Clark41 filings
  • Amirali Talasaz40 filings
  • Stanley J Meresman36 filings
  • Eltoukhy Helmy23 filings
  • Musa Tariq20 filings

Ask anything about GH insider activity

Use Trabud's AI agent to query Guardant Health, Inc.'s Form 4 history in plain English — "Show me GH CEO purchases this year" or compare it against any other ticker.

Open the AI agent

GH insider trading FAQ

Are Guardant Health, Inc. insiders buying or selling?

Across 247 SEC Form 4 filings, Guardant Health, Inc. (GH) insiders reported 8 open-market purchases totaling $65.2M and 239 sales totaling $2.9B. That is a net selling position of $2.8B.

How many insiders trade GH stock?

23 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Guardant Health, Inc.. The most recent filing was accepted on Jul 16, 2026.

Where does Trabud get GH insider trading data?

All GH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content